84
Views
10
CrossRef citations to date
0
Altmetric
Expert Opinion

The asthma–COPD overlap syndrome: how is it defined and what are its clinical implications?

&
Pages 27-35 | Published online: 10 Feb 2016

References

  • PostmaDSReddelHKten HackenNHvan den BergeMAsthma and chronic obstructive pulmonary disease: similarities and differencesClin Chest Med201435114315624507842
  • van den BergeMKerstjensHAMeijerRJCorticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholineAm J Respir Crit Care Med200116471127113211673197
  • ChristensonSASteilingKvan den BergeMAsthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2015191775876625611785
  • Global Initiative for Asthma (GINA) ReportGlobal Strategy for Asthma Management and Prevention http://www.ginasthma.org2015
  • Global Strategy for Diagnosis, Management, and Prevention of COPD http://www.goldcopd.org2015
  • Definition and classification of chronic bronchitis for clinical and epidemiological purposes. A report to the Medical Research Council by their Committee on the Aetiology of Chronic BronchitisLancet1965173897757794165081
  • FabbriLMRomagnoliMCorbettaLDifferences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2003167341842412426229
  • de OcaMMHalbertRJLopezMVThe chronic bronchitis phenotype in subjects with and without COPD: the PLATINO studyEur Respir J2012401283622282547
  • BurgelPRNesme-MeyerPChanezPCough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjectsChest2009135497598219017866
  • VestboJPrescottELangePCopenhagen City Heart Study GroupAssociation of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidityAm J Respir Crit Care Med19961535153015358630597
  • LangePParnerJVestboJSchnohrPJensenGA 15-year follow-up study of ventilatory function in adults with asthmaN Engl J Med199833917119412009780339
  • WatsonLVestboJPostmaDSGender differences in the management and experience of Chronic Obstructive Pulmonary DiseaseRespir Med200498121207121315588042
  • KitaguchiYKomatsuYFujimotoKHanaokaMKuboKSputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthmaInt J Chron Obstruct Pulmon Dis2012728328922589579
  • BergeronCTulicMKHamidQAirway remodelling in asthma: from benchside to clinical practiceCan Respir J2010174e85e9320808979
  • BenayounLDruilheADombretMCAubierMPretolaniMAirway structural alterations selectively associated with severe asthmaAm J Respir Crit Care Med2003167101360136812531777
  • VonkJMJongepierHPanhuysenCISchoutenJPBleeckerERPostmaDSRisk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow upThorax200358432232712668795
  • ContoliMBaraldoSMarkuBFixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-upJ Allergy Clin Immunol2010125483083720227753
  • TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
  • AlbertPAgustiAEdwardsLBronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary diseaseThorax201267870170822696176
  • PapiARomagnoliMBaraldoSPartial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200016251773177711069811
  • BleeckerEREmmettACraterGKnobilKKalbergCLung function and symptom improvement with fluticasone propionate/salmeterol and ipratropium bromide/albuterol in COPD: response by beta-agonist reversibilityPulm Pharmacol Ther200821468268818541448
  • KitaguchiYFujimotoKKuboKHondaTCharacteristics of COPD phenotypes classified according to the findings of HRCTRespir Med2006100101742175216549342
  • ReidDWWenYJohnsDPWilliamsTJWardCWaltersEHBronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not relatedRespirology200813679980918811878
  • PerngDWWuCCSuKCLeeYCPerngRPTaoCWInhaled fluticasone and salmeterol suppress eosinophilic airway inflammation in chronic obstructive pulmonary disease: relations with lung function and bronchodilator reversibilityLung2006184421722217006748
  • O’ByrnePMPostmaDSAsthma Research GroupThe many faces of airway inflammation. Asthma and chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19991595 Pt 2S41S6310228145
  • van den BergeMVonkJMGosmanMClinical and inflammatory determinants of bronchial hyperresponsiveness in COPDEur Respir J20124051098110522523354
  • TashkinDPAltoseMDBleeckerERThe Lung Health Study Research GroupThe lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitationAm Rev Respir Dis19921452 Pt 13013101736734
  • PostmaDSWempeJBRenkemaTEvan der MarkTWKoeterGHHyperresponsiveness as a determinant of the outcome in chronic obstructive pulmonary diseaseAm Rev Respir Dis19911436145814622048838
  • PostmaDSKerstjensHACharacteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981585 Pt 3S187S1929817744
  • XuXRijckenBSchoutenJPWeissSTAirways responsiveness and development and remission of chronic respiratory symptoms in adultsLancet19973509089143114349371166
  • PostmaDSde VriesKKoeterGHSluiterHJIndependent influence of reversibility of air-flow obstruction and nonspecific hyperreactivity on the long-term course of lung function in chronic air-flow obstructionAm Rev Respir Dis198613422762802874759
  • RutgersSRKoeterGHvan der MarkTWPostmaDSShort-term treatment with budesonide does not improve hyperresponsiveness to adenosine 5′-monophosphate in COPDAm J Respir Crit Care Med19981573 Pt 18808869517606
  • HardinMChoMMcDonaldMLThe clinical and genetic features of COPD-asthma overlap syndromeEur Respir J201444234135024876173
  • KauppiPKupiainenHLindqvistAOverlap syndrome of asthma and COPD predicts low quality of lifeJ Asthma201148327928521323613
  • FuJJGibsonPGSimpsonJLMcDonaldVMLongitudinal changes in clinical outcomes in older patients with asthma, COPD and asthma-COPD overlap syndromeRespiration2014871637424029561
  • TashkinDPChippsBETrudoFZangrilliJGFixed airflow obstruction in asthma: a descriptive study of patient profiles and effect on treatment responsesJ Asthma201451660360924524222
  • LimHSChoiSMLeeJResponsiveness to inhaled corticosteroid treatment in patients with asthma-chronic obstructive pulmonary disease overlap syndromeAnn Allergy Asthma Immunol2014113665265725280465
  • JonesRCPriceDRyanDOpportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohortLancet Respir Med20142426727624717623
  • PascoeSLocantoreNDransfieldMTBarnesNCPavordIDBlood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trialsLancet Respir Med20153643544225878028
  • BrightlingCEMcKennaSHargadonBSputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary diseaseThorax200560319319815741434